STOCKWATCH
·
Medical/Dental Instruments
Quarterly ResultMay 6, 2026, 04:15 PM

Accuray Withdraws FY26 Guidance; Q3 Net Loss $11.8M

AI Summary

Accuray reported its fiscal 2026 third-quarter financial results, including a net loss of $11.8 million on total net revenue of $104.8 million, a 7% decrease year-over-year. The company withdrew its financial guidance for fiscal year 2026, citing geopolitical uncertainty in the Middle East impacting product shipments and service revenue. Despite the challenges, Accuray noted significant progress on its transformation plan, achieving approximately $10 million in cost and margin improvements, ahead of expectations.

Key Highlights

  • Accuray withdrew its fiscal 2026 financial guidance due to geopolitical uncertainty.
  • Reported Q3 FY26 net loss of $11.8 million, or $0.09 per share.
  • Q3 FY26 total net revenue decreased 7% year-over-year to $104.8 million.
  • Q3 FY26 Adjusted EBITDA was $3.8 million, down from $6.0 million in prior year.
  • Transformation plan achieved $10 million in cost and margin improvements.
  • Gross product orders for Q3 FY26 were $48.5 million, a decrease from $71.2 million YoY.
  • Order backlog as of March 31, 2026, was $356.2 million, 21% lower YoY.
  • Operating expenses included $6.5 million in restructuring charges.
ARAY
Medical/Dental Instruments
ACCURAY INC

Price Impact